|
||
J. Exp. Med.,
Volume 188, Number 5, September 7, 1998 909-917
By


From the * National Jewish Medical and Research Center, Division of Basic Sciences, Department of
Pediatrics, Denver, Colorado 80206; and the Peripheral B cell tolerance was studied in mice of the autoimmune-prone, Fas-deficient MRL/
lpr.H-2d genetic background by introducing a transgene that directs expression of membrane-bound H-2Kb antigen to liver and kidney (MT-Kb) and a second transgene encoding antibody
reactive with this antigen (3-83µ
Department of Immunology, University of Colorado
Health Sciences Center, Denver, Colorado 80206
, anti-Kk,b). Control immunoglobulin transgenic (Ig-Tg)
MRL/lpr.H-2d mice lacking the Kb antigen had large numbers of splenic and lymph node B
cells bearing the transgene-encoded specificity, whereas B cells of the double transgenic (Dbl-Tg) MRL/lpr.H-2d mice were deleted as efficiently as in Dbl-Tg mice of a nonautoimmune B10.D2 genetic background. In spite of the severely restricted peripheral B cell repertoire of
the Ig-Tg MRL/lpr.H-2d mice, and notwithstanding deletion of the autospecific B cell population in the Dbl-Tg MRL/lpr.H-2d mice, both types of mice developed lymphoproliferation
and exhibited elevated levels of IgG anti-chromatin autoantibodies. Interestingly, Dbl-Tg
MRL/lpr.H-2d mice had a shorter lifespan than Ig-Tg MRL/lpr.H-2d mice, apparently as an indirect result of their relative B cell lymphopenia. These data suggest that in MRL/lpr mice peripheral B cell tolerance is not globally defective, but that certain B cells with receptors specific
for nuclear antigens are regulated differently than are cells reactive to membrane autoantigens.
This article has been cited by other articles:
| TABLE OF CONTENTS |
|